Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,583 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector.
Catanzaro AT, Koup RA, Roederer M, Bailer RT, Enama ME, Moodie Z, Gu L, Martin JE, Novik L, Chakrabarti BK, Butman BT, Gall JG, King CR, Andrews CA, Sheets R, Gomez PL, Mascola JR, Nabel GJ, Graham BS; Vaccine Research Center 006 Study Team. Catanzaro AT, et al. Among authors: gu l. J Infect Dis. 2006 Dec 15;194(12):1638-49. doi: 10.1086/509258. Epub 2006 Nov 8. J Infect Dis. 2006. PMID: 17109335 Free PMC article. Clinical Trial.
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial.
Martin JE, Sullivan NJ, Enama ME, Gordon IJ, Roederer M, Koup RA, Bailer RT, Chakrabarti BK, Bailey MA, Gomez PL, Andrews CA, Moodie Z, Gu L, Stein JA, Nabel GJ, Graham BS. Martin JE, et al. Among authors: gu l. Clin Vaccine Immunol. 2006 Nov;13(11):1267-77. doi: 10.1128/CVI.00162-06. Epub 2006 Sep 20. Clin Vaccine Immunol. 2006. PMID: 16988008 Free PMC article. Clinical Trial.
Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals.
Parrino J, McCurdy LH, Larkin BD, Gordon IJ, Rucker SE, Enama ME, Koup RA, Roederer M, Bailer RT, Moodie Z, Gu L, Yan L, Graham BS; VRC 201/203 Study Team. Parrino J, et al. Among authors: gu l. Vaccine. 2007 Feb 9;25(8):1513-25. doi: 10.1016/j.vaccine.2006.10.047. Epub 2006 Nov 7. Vaccine. 2007. PMID: 17126963 Free PMC article. Clinical Trial.
Symptom-to-balloon time and risk of ventricular arrhythmias in patients with STEMI undergoing percutaneous coronary intervention: The VERY-STEMI study.
Shan TK, Qian LL, Han XD, Deng B, Gu LF, Wang ZM, He Y, Zhu T, Jing P, Wang QM, Wang ZD, Wang RX, Wang SB, Wang LS. Shan TK, et al. Among authors: gu lf. Int J Cardiol Cardiovasc Risk Prev. 2024 May 16;21:200286. doi: 10.1016/j.ijcrp.2024.200286. eCollection 2024 Jun. Int J Cardiol Cardiovasc Risk Prev. 2024. PMID: 38813099 Free PMC article.
Ultrastrong and ductile medium-entropy alloys via hierarchical ordering.
Gu L, Zhao Y, Li Y, Hou R, Liang F, Zhang R, Wu Y, Fan Y, Liang N, Zhou B, Chen Y, Sha G, Chen G, Wang Y, Chen X. Gu L, et al. Sci Adv. 2024 May 31;10(22):eadn7553. doi: 10.1126/sciadv.adn7553. Epub 2024 May 29. Sci Adv. 2024. PMID: 38809970 Free PMC article.
6,583 results